2-phenyltetrahydro-2H-pyran-2-ol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧烷类
• 英文名称: 2-phenyltetrahydro-2H-pyran-2-ol
• 英文别名: 2-phenyloxan-2-ol
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: XNRQWQPRYUJICE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-phenyltetrahydro-2H-pyran-2-ol 在 三乙基硅烷 、 三氟化硼乙醚 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 2-phenyltetrahydropyran
  参考文献：
  名称：

  An Efficient and Stereoselective Conversion of Lactones to Substituted Cyclic Ethers

  摘要：

  A general route to substituted cyclic ethers has been described by using nucleophilic addition of Grignard reagents to lactones in the presence of CeCl3 followed by the Lewis acid-induced deoxygenation of the corresponding hemiketals with Et3SiH. Stereoselective reduction of the 5-membered adducts to the disubstituted tetrahydrofurans has been also investigated.

  DOI：

  10.3987/com-97-8060
• 作为产物：
  描述：

  delta-戊内酯 、 苯基溴化镁 以 四氢呋喃 为溶剂， 反应 5.0h， 生成 2-phenyltetrahydro-2H-pyran-2-ol
  参考文献：
  名称：

  [EN] SUBSTITUTED 3-PHENYL-1,2,4-OXADIAZOLE COMPOUNDS
  [FR] COMPOSÉS 3-PHÉNYL-1,2,4-OXADIAZOLE SUBSTITUÉS

  摘要：

  本文揭示了Formula (I)的化合物：(I)或其立体异构体、盐或前药，其中：(i) R1和R2独立地为C1-C4烷基，或者(ii) R1和R2与它们连接的碳原子一起形成一个环状基团；Q为H，C1-6烷基，苯基或带有零至3个取代基的5-至6-成员杂环芳基；G在此处有定义。还揭示了使用这些化合物作为G蛋白偶联受体S1P1的选择性激动剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗、预防或减缓多种治疗领域的疾病或疾病的进展方面具有用途，例如自身免疫疾病和慢性炎症性疾病。

  公开号：

  WO2012012477A1

文献信息

• [EN] HOMOALLYL ALCOHOLS USEFUL AS FRAGRANCES<br/>[FR] ALCOOLS HOMOALLYLIQUES CONVENANT COMME PARFUMS
  申请人：GIVAUDAN SA

  公开号：WO2009065244A1

  公开（公告）日：2009-05-28

  Branched, highly-substituted C9-C13 homoallyl alcohols of formula (I) in which R1 and R2 are selected from H or Me and R3 is selected from H, Me and Et. The compounds are useful in fragrance applications in which a floral note is desired.

  公式（I）中R1和R2从H或Me中选择，R3从H，Me和Et中选择的分支，高度取代的C9-C13同烯基醇。这些化合物在需要花香调的香精应用中很有用。
• [EN] SUBSTITUTED 3-PHENYL-1,2,4-OXADIAZOLE COMPOUNDS<br/>[FR] COMPOSÉS 3-PHÉNYL-1,2,4-OXADIAZOLE SUBSTITUÉS
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2012012477A1

  公开（公告）日：2012-01-26

  Disclosed are compounds of Formula (I): (I) or stereoisomers, salts, or prodrugs thereof, wherein: (i) R1 and R2 are independently C1-C4 alkyl, or (ii) R1 and R2 together with the carbon atom to which they are attached, form a cyclic group; and Q is H, C1-6alkyl, phenyl or 5- to 6-membered heteroaryl substituted with zero to 3 substituents, and G is defined herein. Also disclosed are method of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. There compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and chronic inflammatory disease.

  本文揭示了Formula (I)的化合物：(I)或其立体异构体、盐或前药，其中：(i) R1和R2独立地为C1-C4烷基，或者(ii) R1和R2与它们连接的碳原子一起形成一个环状基团；Q为H，C1-6烷基，苯基或带有零至3个取代基的5-至6-成员杂环芳基；G在此处有定义。还揭示了使用这些化合物作为G蛋白偶联受体S1P1的选择性激动剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗、预防或减缓多种治疗领域的疾病或疾病的进展方面具有用途，例如自身免疫疾病和慢性炎症性疾病。
• [EN] SUBSTITUTED OXADIAZOLE COMPOUNDS AND THEIR USE AS S1P1 AGONISTS<br/>[FR] COMPOSÉS OXADIAZOLES SUBSTITUÉS ET LEUR UTILISATION EN TANT QU'AGONISTES DU S1P1
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2012040532A1

  公开（公告）日：2012-03-29

  Disclosed are compounds of Formula (I): [PLEASE INSERT CHEMICAL STRUCTURE HERE] or stereoisomers, N-oxides, salts, or prodrugs thereof; wherein: Ring A is phenyl or 5- to 6-membered heteroaryl; (i) R1 and R2 are independently C1-C4 alkyl; or (ii) R1 and R2 together with the carbon atom to which they are attached, form a cyclic group; Q is phenyl or 5- to 6-membered heteroaryl substituted with zero to 3 substituents; and R3, L1, L2, and n are defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P1, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

  公开了式(I)的化合物：[请在此处插入化学结构]或其立体异构体、N-氧化物、盐或前药；其中：环A是苯基或5至6元杂芳基；(i) R1和R2各自独立地是C1-C4烷基；或(ii) R1和R2与其所连接的碳原子一起形成一个环状基团；Q是带有零至3个取代基的苯基或5至6元杂芳基；并且R3、L1、L2和n如本文所定义。还公开了使用这些化合物作为G蛋白偶联受体S1P1的选择性激动剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗、预防或减缓各种治疗领域中的疾病或障碍的进展方面有用，例如自身免疫性疾病和血管疾病。
• [EN] HIGH-COVERAGE, LOW ODOR MALODOR COUNTERACTANT COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS AGISSANT CONTRE LES MAUVAISES ODEURS, À FAIBLE ODEUR ET À POUVOIR COUVRANT ÉLEVÉ, ET PROCÉDÉS D'UTILISATION
  申请人：INT FLAVORS & FRAGRANCES INC

  公开号：WO2016049523A1

  公开（公告）日：2016-03-31

  The present invention relates to novel compounds and their use as malodor counteractant materials.

  本发明涉及新化合物及其作为恶臭对抗剂材料的用途。
• [EN] FRAGRANCE AND FLAVOR MATERIALS<br/>[FR] MATÉRIAUX DE PARFUM ET D'ARÔME
  申请人：TAKASAGO INT CORPORATION USA

  公开号：WO2018119466A1

  公开（公告）日：2018-06-28

  The present disclosure is directed to the synthesis and application of undecavertol derivatives having unique and desired flavor and/or fragrant characteristics. The compounds of the present disclosure can be employed alone or incorporated as fragrance or flavor ingredients in fragrance or flavor compositions. The present disclosure is also directed to consumer products comprising such derivatives and/or fragrance or flavor compositions.

  本公开涉及合成和应用具有独特和理想风味和/或芳香特性的十一萜醇衍生物。本公开的化合物可以单独应用，也可以作为香精或风味成分并入香精或风味配方中。本公开还涉及包含这些衍生物和/或香精或风味配方的消费者产品。